Watch Ticker

Renovaro Inc. Common Stock

Go to Renovaro Inc. Common Stock Website

$0.26

0.00 (0.98%)

Live

Previous Close

$0.2585

Day Range

$0.2506 - $0.27

Previous Day Range

$0.255 - $0.29

Market Cap

$59.7 million USD

Day Vol.

578460

Previous Day Vol.

1.9 million

Currency

USD

Primary Exchange

None

Renovaro Inc is a biopharmaceutical company. It is engaged in developing new immunotherapies to combat cancer and developing a predicative artificial intelligence-based diagnostic methodology for the use of earlier cancer detection....

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Prnewswire - AI Just Got a Green Light from the White House--Here's What That Means for Healthcare Stocks

The White House is encouraging AI adoption in healthcare through regulatory sandboxes, with several tech and biotech companies advancing AI-powered healthcare solutions focused on diagnostics, drug development, and workflow optimization.

Related tickers: AVAI, RENB, HCTI, GEHC, MDAI, MDAIW.

Read Full Article

Globe Newswire - UPDATE - Renovaro Inc. Announces Expedited Trial for 2025 Lawsuit to Enforce Binding Merger Agreement with Predictive Oncology

Renovaro Inc. has received a ruling to expedite a trial in 2025 for a lawsuit it filed against Predictive Oncology Inc., seeking to enforce a binding merger agreement executed on January 1, 2025. Renovaro alleges that Predictive Oncology breached the agreement's exclusivity and good faith negotiation provisions.

Related tickers: RENB, POAI.

Read Full Article

Trending Tickers

Please sign in to view